REEDER, THADDEUS CROMWELL,MOORE, MARK WADE,LORENZ, DOUGLAS ALAN,LYON, DAVID KEITH
申请号：
CA2899032
公开号：
CA2899032A1
申请日:
2014.01.31
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.
